Core Acupoints and Acupoint Combination Patterns for Acupuncture Treatment of Discogenic Low Back Pain: A Data Mining Study Authors: Yiqi Dong, Yunyun Xu, Shuwen Wu, Qingzhong Lai, Fangjun Wang, Wen Zha, Qiang Zhan Published: 2026 ABSTRACT BackgroundDiscogenic low back pain (DLBP) is a distinct subtype of chronic low back pain arising from intradiscal degeneration in the absence of nerve root compression. Previous data-mining studies on acupuncture have focused largely on lumbar disc herniation (LDH), creating a gap in evidence for DLBP-specific acupoint selection.ObjectiveTo systematically identify acupuncture prescription rules for DLBP using data-mining techniques.MethodsEight databases were searched for clinical studies on acupuncture for DLBP (2016–2025). We analyzed acupoint frequency, association rules, and hierarchical clustering to identify core prescription patterns.ResultsA total of 57 studies involving 41 acupoints were included in the analysis. The five most frequently utilized acupoints were BL40 (Weizhong), BL25 (Dachangshu), Ashi points, EX-B2 (Jiaji), and BL23 (Shenshu). Standard treatment protocols typically involved needle retention for 30 minutes per session, administered once daily. Warm-needle acupuncture or moxibustion was incorporated in approximately 32% of the treatment regimens. Data mining identified two principal association patterns: (1) intra‑meridian pairings within the Governor Vessel (Du Meridian), and (2) synergistic combinations targeting lower‑limb acupoints. Hierarchical clustering further yielded three clinically meaningful acupoint clusters: (i) distal points for systemic meridian regulation, (ii) local lumbar points for segmental symptom control, and (iii) syndrome‑specific points guided by Traditional Chinese Medicine pattern differentiation. Notably, compared with prescriptions for lumbar disc herniation (LDH), those for discogenic low back pain (DLBP) demonstrated a stronger emphasis on local and warming interventions particularly warm‑needle acupuncture and moxibustion and less reliance on distal Gallbladder meridian points.ConclusionThis first dedicated data-mining study for DLBP reveals a distinct acupoint selection paradigm of “warming and dispersing cold, local precision”, differing from the LDH pattern of “activating blood and unblocking meridians distally”. These findings provide a quantitative evidence base for developing diagnosis-specific acupuncture protocols. Introduction DLBP is a chronic, non-radicular low back pain syndrome primarily attributable to structural disruption and biochemical dysregulation within the lumbar intervertebral disc. Its core pathophysiological mechanisms include intrinsic disc degeneration, annular fissures, and vertebral endplate microfractures each triggering localized neuroinflammatory responses that sensitize intra-discal and peri-endplate nociceptors distinct from radicular pain caused by mechanical compression of nerve roots due to nucleus pulposus herniation. Globally, chronic low back pain affects approximately 619 million individuals, with DLBP representing a well-defined, pathoanatomically distinct phenotype among disc-related conditions.1,2 As the most prevalent *diagnostically confirmed* cause of chronic non-specific low back pain, DLBP accounts for an estimated 35–40% of cases in cohorts rigorously phenotyped using MRI-confirmed disc pathology and clinical criteria.3 This growing burden is strongly associated with modifiable lifestyle factors including prolonged sedentary behavior, physical inactivity, and increasing obesity prevalence established drivers of accelerated disc degeneration and persistent nociceptive signaling. DLBP and LDH exhibit fundamentally distinct pathophysiological mechanisms. Lumbar disc herniation (LDH) is characterized by mechanical compression or chemical irritation of spinal nerve roots primarily attributable to extrusion or sequestration of the nucleus pulposus and is classically associated with radicular symptoms. In contrast, discogenic low back pain (DLBP) originates from nociceptive signaling within the intervertebral disc: progressive disc degeneration leads to annular fissuring, pathological neovascularization, and aberrant ingrowth of sensory nerve fibers into the normally avascular inner annulus, accompanied by localized neuroinflammation. These structural and inflammatory alterations establish an intradiscal “pain generator” that underlies the persistent nociceptive drive in DLBP.4,5 Consistent with its intradiscal pathobiology, DLBP is clinically characterised by deep, dull, aching, and distending pain localised to the lumbar region typically diffuse, poorly localised, and lacking dermatomal distribution. Crucially, it is not associated with radicular leg pain or objective neurological signs; when referred pain occurs, it remains confined to the gluteal region and proximal thigh without extending below the knee.6 Pain intensity is consistently exacerbated by sustained mechanical loading of the disc: prolonged sitting (>20–30 minutes), prolonged standing, forward flexion, and rotational movements including turning over in bed while being markedly alleviated by supine rest, which unloads the intervertebral disc.7 Notably, seated tolerance is significantly impaired in DLBP patients: most report intolerable lumbar aching and distension after 20–30 minutes of uninterrupted sitting, necessitating frequent postural shifts or standing to achieve symptomatic relief.2 This functional limitation imposes substantial occupational burden particularly among office workers requiring prolonged sedentary engagement and manual labourers exposed to repetitive lifting, heavy load carriage, or whole-body vibration.8 Current first-line management of DLBP remains predominantly conservative. Conventional Western medical interventions include non-steroidal anti-inflammatory drugs (NSAIDs), skeletal muscle relaxants, physical therapy, structured rehabilitation programmes, and image-guided intradiscal injections.2 However, each modality exhibits well-documented limitations. While NSAIDs and muscle relaxants offer transient symptomatic relief,9 their long-term use is associated with clinically significant gastrointestinal toxicity, renal impairment, and increased cardiovascular risk.10 Physical therapy and rehabilitation demonstrate modest clinical efficacy in managing chronic low back pain; however, their real-world effectiveness is frequently limited by suboptimal patient adherence, as reported in multiple studies.11,12 Minimally invasive interventions including transforaminal epidural steroid injections, radiofrequency ablation, and intradiscal biologics lack high-quality, long-term comparative effectiveness data, and carry procedure-specific risks such as infection, nerve injury, or transient exacerbation of symptoms.13 For refractory cases, lumbar fusion surgery remains an option, but its invasiveness and prolonged recovery restrict its use.14 Collectively, these constraints underscore the urgent need for an effective, safe, and patient-centred therapeutic alternative for DLBP. Acupuncture among the most extensively utilised and empirically validated external interventions in traditional Chinese medicine (TCM) has a long-standing clinical tradition in managing low back pain. Contemporary neurobiological and immunomodulatory research demonstrates that its analgesic mechanisms are multifaceted: including endogenous opioid system activation (eg, β-endorphin, enkephalin release), suppression of pro-inflammatory cytokine expression (eg, TNF-α, IL-1β), and enhancement of local microcirculation and tissue oxygenation.15 Clinical evidence supports its efficacy in LDH: multiple randomised controlled trials (RCTs) report statistically significant and clinically meaningful reductions in pain intensity (eg, ≥2-point decrease on 0–10 NRS) and improvements in functional outcomes (eg, ODI scores).16 A prior data mining study specifically targeting LDH further identified BL40 (Weizhong, 9.7%), GB30 (Huantiao, 8.5%), and BL25 (Dachangshu, 8.3%) as the most frequently prescribed acupoints reflecting a therapeutic strategy emphasising distal meridian regulation and local musculoskeletal relief.17 Critically, however, all these findings pertain exclusively to LDH. As established earlier, DLBP and LDH are etiologically and phenotypically distinct disorders: DLBP originates from intradiscal nociception and neuroinflammation, whereas LDH is driven by mechanical and chemical radicular irritation. Consequently, acupuncture protocols empirically derived for LDH lack pathophysiological rationale for direct translation to DLBP and may even risk suboptimal targeting or unintended physiological effects. Moreover, the majority of existing mechanistic acupuncture studies have employed non-specific low back pain or LDH animal and clinical models; dedicated investigations into DLBP-specific neurobiological pathways remain scarce. Given that DLBP pain arises from intradiscal neuroinflammatory cascades not nerve root compression, its pathophysiological profile aligns more closely with inflammatory nociception and deep somatic referred pain, rather than the radicular neuropathic pain characteristic of LDH. Grounded in this fundamental pathobiological divergence, we hypothesise that optimal acupoint selection for DLBP follows a distinct, mechanism-informed paradigm: prioritising local anti-inflammatory modulation (eg, Ashi points and EX-B2 Jiaji) and thermoregulatory neuromodulation via Governor Vessel acupoints (eg, GV3 Yaoyangguan and GV4 Mingmen) a strategy we term “heat-sensitive warming” while de-emphasising the distal meridian regulation approach central to LDH treatment. Critically, this hypothesis remains untested; rigorous data mining and empirical validation are required to confirm whether DLBP-specific acupoint patterns exist and to delineate their clinical relevance. To date, no study has conducted a methodologically rigorous, systematic data mining analysis of acupuncture prescriptions specifically for DLBP a critical evidence gap that urgently requires closure. Data mining represents a robust, reproducible computational methodology widely validated for uncovering latent patterns in heterogeneous clinical datasets, enabling objective identification of high-frequency acupoints and statistically significant co-prescription relationships. In this study, we implement a three-tiered analytical framework: (1) frequency analysis to quantify clinical usage intensity of individual acupoints; (2) Apriori-based association rule mining with moderate support and confidence thresholds to identify clinically relevant core acupoint pairs; and (3) Ward’s minimum-variance hierarchical clustering to group high-frequency acupoints according to anatomical proximity and functional synergy thereby integrating empirical usage patterns with neuroanatomical and physiological plausibility to reveal DLBP-specific acupoint architecture and compatibility logic. This study constitutes the first dedicated, LDH-excluded data mining investigation of acupuncture prescriptions for DLBP. Its primary aim is to empirically delineate DLBP-specific acupoint selection patterns distinct from those established for lumbar disc herniation and to establish a mechanistically grounded, clinically actionable, and LDH-independent evidence base for acupuncture intervention in DLBP. Methods Literature Search Strategy A comprehensive literature search was conducted across eight international and Chinese bibliographic databases PubMed, Embase, Web of Science, Cochrane Library, China Biology Medicine (CBM), Wanfang Data, VIP Information Resource System, and China National Knowledge Infrastructure (CNKI) to identify peer-reviewed studies on acupuncture for DLBP published between January 1, 2016 and December 31, 2025. No language restrictions were applied. The search strategy employed both controlled vocabulary (eg, MeSH terms “Low Back Pain”, “Intervertebral Disc Degeneration”) and free-text keywords, including: (a) DLBP-related terms “discogenic low back pain”, “discogenic back pain”, “internal disc disruption”, “annular fissure”, “intervertebral disc degeneration”, and “DLBP”; and (b) acupuncture-related terms “acupuncture”, “acupuncture therapy”, “electroacupuncture”, “warm needle acupuncture”, along with their standardized Chinese equivalents for the CNKI, Wanfang, VIP, and CBM databases. Additionally, the reference lists of all included studies were manually screened to identify potentially eligible reports not captured by the database searches. This study constitutes a secondary analysis of publicly available, ethically approved clinical literature and does not involve any primary human or animal experimentation. Inclusion and Exclusion Criteria Inclusion criteria: (1) Study design: randomised controlled trials (RCTs), clinical controlled trials, or observational studies (prospective or retrospective); (2) Participants: adults (≥18 years) with a confirmed diagnosis of DLBP, established strictly according to internationally accepted diagnostic criteria requiring objective imaging confirmation via magnetic resonance imaging (MRI), computed tomography (CT), or provocation discography; (3) Intervention: acupuncture as the primary therapeutic modality including manual acupuncture, electroacupuncture, warm needle acupuncture, or acupuncture combined with moxibustion administered alone or as the dominant component in combination with conventional treatment (eg, NSAIDs, physical therapy), with full documentation of acupoint selection (including precise anatomical location per WHO Standard Acupoint Locations), manipulation technique, treatment frequency, and duration; (4) Outcomes: reporting of at least one standardised, psychometrically validated primary outcome measure (eg, visual analogue scale [VAS], Roland–Morris Disability Questionnaire [RMDQ], or Oswestry Disability Index [ODI]) with clearly presented pre- and post-intervention scores or change values. Exclusion criteria: (1) Reviews, case reports, animal studies, in vitro experiments, or theoretical commentaries; (2) Duplicate publications, conference abstracts, editorials, or studies not published as full-text articles in English or Chinese; (3) Studies with incomplete acupoint prescriptions including omission of key parameters (eg, laterality, depth of insertion, needle retention time) or unspecified acupoint locations (eg, “local Ashi points” without anatomical description); (4) Absence of explicit DLBP diagnostic criteria, failure to report imaging confirmation, ambiguous differentiation from LDH, or diagnosis based solely on non-specific low back pain criteria; (5) Studies in which acupuncture was used exclusively as a minor adjunctive intervention (eg, <20% of total treatment sessions) without isolated reporting of its therapeutic contribution; (6) Use of acupoints deviating from the WHO Standard Acupoint Locations (2008 edition) or application of unconventional point selection strategies lacking documented clinical rationale or empirical support; (7) Sample size <20 participants per intervention group; (8) Studies assessed as high risk of bias across ≥2 domains using the Cochrane Risk-of-Bias Tool (for RCTs) or the ROBINS-I tool (for non-randomised studies). Literature Screening and Data Extraction Zotero 7.0 was used for literature management and automated deduplication. Two independent investigators both trained in acupuncture clinical practice and systematic review methodology conducted blinded, two-stage screening: (1) title and abstract screening to exclude clearly irrelevant studies, and (2) full‑text assessment to determine eligibility against all inclusion and exclusion criteria. Disagreements were resolved through consensus discussion, with adjudication by a third senior investigator when consensus could not be reached. Data extraction was performed using a piloted, standardised electronic form and verified via dual independent entry followed by cross‑checking. Extracted fields included: first author, journal name, publication year, study design (eg, RCT, clinical controlled trial, cohort study), total sample size and group distribution, complete acupuncture prescription (acupoint names, associated meridians, specific point categories [eg, Five Shu points, Back‑Shu points, Front‑Mu points], laterality, and anatomical location per the WHO Standard Acupoint Locations, 2008 edition), treatment parameters (needle retention time per session, treatment frequency per week, total duration in weeks, needle specifications [gauge and length]), use of warm needle acupuncture or electroacupuncture (yes/no, with stimulation parameters recorded if reported), and primary outcome measures (including instrument name, scoring method, and time points of assessment). Data Standardisation All acupoint names extracted from included prescriptions were standardised according to two authoritative references: the WHO Standard Acupoint Locations (Western Pacific Region, 2008 edition) and the Chinese National Standard Nomenclature and Location of Acupoints on Meridians (GB/T 12346–2021). Discrepancies between original reporting (eg, “BL23”, “Shenshu”, “Kidney Shu”) and standard nomenclature were resolved by cross-referencing anatomical descriptions and consensus adjudication by two TCM acupuncture specialists. For all 41 acupoints included in this study, the GB/T 12346–2021 and WHO 2008 Standard Acupuncture Locations were fully concordant, with no discrepancies in acupoint codes or names identified between the two standards. Following standardisation, each acupoint was encoded as a binary variable (1 = used in the prescription; 0 = not used), forming a structured, analysis-ready dataset for subsequent frequency analysis, association rule mining, and hierarchical clustering. Data Analysis All statistical analyses and visualisations were conducted in R 4.6.0 (R Core Team, 2025). Descriptive statistics summarised acupoint usage frequency, meridian distribution, specific point categories (eg, Five Shu, Back-Shu, Front-Mu), and treatment parameters (needle retention time, weekly frequency, total duration, needle specifications). Association rule mining was performed using the arules package with the Apriori algorithm under the following prespecified thresholds: minimum support ≥4%, minimum confidence ≥65%, maximum antecedent length = 3, and lift >1.0 rules meeting all criteria were retained for interpretation. Network visualisation of significant rules was generated using arulesViz. Hierarchical clustering was applied to acupoints with a raw usage frequency of ≥3 occurrences across all included prescriptions; distance was computed using squared Euclidean distance, and cluster linkage employed Ward’s minimum-variance method. The optimal number of clusters was determined objectively by integrating dendrogram inspection with the elbow criterion applied to within-cluster sum of squares. Visual outputs including cluster heatmaps (pheatmap), meridian distribution radar charts (ggplot2), and radial acupoint co-occurrence networks (ggraph) were generated to illustrate patterns of acupoint selection, meridian affinity, and synergistic compatibility. Ethical Considerations This study is a secondary analysis of publicly available, peer-reviewed literature and involves no collection, generation, or handling of original human or animal data. As such, it does not constitute human or animal subject research under international ethical frameworks (eg, Declaration of Helsinki, ICH-GCP) or national regulations (eg, China’s Measures for the Ethical Review of Biomedical Research Involving Humans), and formal ethics approval was not required. All methodological procedures including literature screening, data extraction, acupoint standardisation, and statistical analysis were conducted in strict adherence to established guidelines for systematic reviews and data mining studies (eg, PRISMA-ScR, STROBE-SD). Results Literature Search and Screening Process A total of 4754 records were identified across the eight databases. After automated deduplication in Zotero 7.0, 2369 duplicate records were removed, leaving 2385 unique records. Title and abstract screening excluded 2211 records that were clearly ineligible (eg, irrelevant conditions, non-clinical study designs, or language exclusions). Full-text assessment was then conducted for the remaining 174 records; of these, 117 were excluded for failing to meet one or more eligibility criteria: 12 studies had an insufficient sample size (<20 participants per intervention group), 8 were assessed as having a high risk of bias (per Cochrane RoB 2.0 or ROBINS-I), and 97 were excluded for other reasons, including ambiguous or non-imaging‑confirmed DLBP diagnosis (n=34), use of acupuncture as a minor adjunctive component without isolated reporting (n=28), incomplete acupoint prescription (n=22), deviation from WHO‑standard acupoint locations (n=8), or failure to report standardised outcome measures (n=5). The remaining 57 studies met all inclusion criteria and were included in the final analysis. The literature selection process is summarised in the PRISMA‑compliant flow diagram (Figure 1). Figure 1Flowchart of literature screening.Identification of studies via databases and registers begins with records identified from various sources: PubMed (135), Embase (845), Web of Science (272), Cochrane Library (1815), CNKI (43), Wanfang (450), vip (742) and CBM (452). Records removed before screening include 2369 duplicate records, with none marked as ineligible by automation tools or removed for other reasons. Records screened total 2385, with 2211 excluded. Reports sought for retrieval number 174, with 3 not retrieved. Reports assessed for eligibility total 171, with 114 excluded for reasons such as incomplete reporting of acupoint prescription (36), unclear or insufficient diagnostic criteria (25), insufficient sample size (less than 20) (11), acupuncture not used as primary intervention (32) and treatment approach too complex (10). Studies included in the review total 57, with reports of included studies also numbering 57.Flowchart of study identification and screening process for inclusion in a review. Flowchart of literature screening. Frequency of Use of Needle Specifications The most frequently reported needle specification was 0.30 mm × 40 mm, appearing in 42.3% of the 52 studies that documented needle parameters. The next most common specifications were 0.30 mm × 50 mm (13.5%) and 0.25 mm × 40 mm (13.5%). Notably, needles with a length ≥50 mm (“long needles”) were reported in 18 studies (34.6% of the 52 studies providing needle specifications), including: 0.30 mm × 50 mm (n=7), 0.30 mm × 60 mm (n=1), 0.30 mm × 125 mm (n=1), 0.30 mm × 150 mm (n=1), 0.35 mm × 50 mm (n=2), 0.35 mm × 60 mm (n=1), 0.35 mm × 75 mm (n=3), 0.35 mm × 125 mm (n=1), and 0.40 mm × 100 mm (n=1). Table 1 Distribution of needle specifications. Table 1Distribution of Needle SpecificationsNeedle SpecificationNumber of Studies (n)Frequency (%)0.30 mm × 40 mm2242.3%0.30 mm × 50 mm713.5%0.25 mm × 40 mm713.5%0.35 mm × 40 mm35.8%0.35 mm × 75 mm35.8%0.35 mm × 50 mm23.8%Others*815.4%Notes: *Other specifications included 0.35 mm × 60 mm, 0.25 mm × 25 mm, 0.35 mm × 20 mm, 0.35 mm × 125 mm, 0.30 mm × 60 mm, 0.30 mm × 125 mm, 0.30 mm × 150 mm, and 0.40 mm × 100 mm (one study each). Table 1Distribution of Needle SpecificationsNeedle SpecificationNumber of Studies (n)Frequency (%)0.30 mm × 40 mm2242.3%0.30 mm × 50 mm713.5%0.25 mm × 40 mm713.5%0.35 mm × 40 mm35.8%0.35 mm × 75 mm35.8%0.35 mm × 50 mm23.8%Others*815.4%Notes: *Other specifications included 0.35 mm × 60 mm, 0.25 mm × 25 mm, 0.35 mm × 20 mm, 0.35 mm × 125 mm, 0.30 mm × 60 mm, 0.30 mm × 125 mm, 0.30 mm × 150 mm, and 0.40 mm × 100 mm (one study each). Distribution of Needle Specifications Notes: *Other specifications included 0.35 mm × 60 mm, 0.25 mm × 25 mm, 0.35 mm × 20 mm, 0.35 mm × 125 mm, 0.30 mm × 60 mm, 0.30 mm × 125 mm, 0.30 mm × 150 mm, and 0.40 mm × 100 mm (one study each). Treatment Frequency Among the 57 included studies reporting treatment frequency, once-daily administration (qd) was the most prevalent regimen, applied in 37 studies (64.9%). This was followed by every-other-day treatment (qod; n=8, 14.0%), three times per week (tiw; n=6, 10.5%), five times per week (n=4, 7.0%), and twice-daily treatment (bid; n=1, 1.8%) (Table 2). Notably, a single study focused on acute DLBP employed a one-session intervention protocol, with outcome assessment conducted immediately post-treatment to evaluate rapid analgesic effect, aligning with clinical priorities for acute-phase symptom control. Table 2Treatment FrequencyTreatment FrequencyNumber of Studies (n)Frequency (%)Once daily (qd)3764.9%Once every other day (qod)814.0%Three times per week (tiw)610.5%Five times per week47.0%Twice daily (bid)11.8%Single session (immediate)11.8% Table 2Treatment FrequencyTreatment FrequencyNumber of Studies (n)Frequency (%)Once daily (qd)3764.9%Once every other day (qod)814.0%Three times per week (tiw)610.5%Five times per week47.0%Twice daily (bid)11.8%Single session (immediate)11.8% Treatment Frequency Needle Retention Time Among the 55 studies reporting needle retention time, 30 minutes was the most frequently applied duration (n=33, 60.0%), followed by 20 minutes (n=8, 14.5%) and a range of 30–40 minutes (n=7, 12.7%) (Table 3). Less common durations included 15–20 minutes, 15 minutes, 20–30 minutes, and 25 minutes each reported in a single study (n=1, 1.8% each). Additionally, three studies used moxibustion cone count as a surrogate measure of treatment duration: two studies employed two cones per session, and one study used three cones per session. Table 3Needle Retention TimeNeedle Retention TimeNumber of Studies (n)Percentage (%)30 minutes3360.0%20 minutes814.5%30–40 minutes712.7%15–20 minutes11.8%15 minutes11.8%20–30 minutes11.8%25 minutes11.8%2 moxa cones per session23.6%3 moxa cones per session11.8% Table 3Needle Retention TimeNeedle Retention TimeNumber of Studies (n)Percentage (%)30 minutes3360.0%20 minutes814.5%30–40 minutes712.7%15–20 minutes11.8%15 minutes11.8%20–30 minutes11.8%25 minutes11.8%2 moxa cones per session23.6%3 moxa cones per session11.8% Needle Retention Time Total Treatment Course Among the 55 included studies reporting total treatment course, the number of sessions ranged from 1 to 40. The full distribution is presented in Table 4. Stratified by predefined duration categories short (6–15 sessions), medium (18–24 sessions), and long (28–40 sessions) short courses were most prevalent (n=25, 45.5%), followed by long courses (n=14, 25.5%) and medium courses (n=5, 9.1%). The single most frequently reported course length was 14 sessions (n=10, 18.2%), followed by 28 sessions (n=8, 14.5%) and 20 sessions (n=6, 10.9%). Table 4Total Treatment CourseTotal Course(Number of Sessions)Number of Studies (n)Percentage (%)14 sessions1018.2%28 sessions814.5%20 sessions610.9%30 sessions59.1%7 sessions59.1%24 sessions47.3%12 sessions47.3%10 sessions35.5%9 sessions35.5%Others*712.7%Notes: *Other courses included immediate (single session), 40, 18, 15, 14–28 (flexible range), 8, and 6 sessions (one study each). Table 4Total Treatment CourseTotal Course(Number of Sessions)Number of Studies (n)Percentage (%)14 sessions1018.2%28 sessions814.5%20 sessions610.9%30 sessions59.1%7 sessions59.1%24 sessions47.3%12 sessions47.3%10 sessions35.5%9 sessions35.5%Others*712.7%Notes: *Other courses included immediate (single session), 40, 18, 15, 14–28 (flexible range), 8, and 6 sessions (one study each). Total Treatment Course Notes: *Other courses included immediate (single session), 40, 18, 15, 14–28 (flexible range), 8, and 6 sessions (one study each). Notably, one study on acute DLBP employed a single-session protocol with immediate post-treatment assessment, explicitly designed to evaluate rapid analgesic effect rather than sustained therapeutic consolidation. Another study adopted a flexible course range of 14–28 sessions, with session count individualised according to clinical response. Collectively, these patterns suggest a bimodal distribution in treatment course selection for DLBP: shorter courses (6–15 sessions) predominate in acute or mild presentations, whereas longer courses (28–40 sessions) are preferentially applied in chronic, recurrent, or severe cases consistent with clinical staging principles in TCM and Western pain management guidelines. Frequency of Use of Moxibustion and Electroacupuncture Among the 57 included studies, 18 (31.6%) incorporated moxibustion or warm-needle acupuncture, and 15 (26.3%) employed electroacupuncture; four studies (7.0%) utilised both modalities concurrently (Table 5). Table 5Frequency of Use of Moxibustion and ElectroacupunctureModalityNumber of Studies (n)Percentage (%)Including concurrent useMoxibustion or warm-needle acupuncture (including concurrent use)1831.6%Electroacupuncture (including concurrent use)1526.3%Mutually exclusive categoriesMoxibustion or warm-needle acupuncture only1424.6%Electroacupuncture only1119.3%Both modalities concurrently47.0% Table 5Frequency of Use of Moxibustion and ElectroacupunctureModalityNumber of Studies (n)Percentage (%)Including concurrent useMoxibustion or warm-needle acupuncture (including concurrent use)1831.6%Electroacupuncture (including concurrent use)1526.3%Mutually exclusive categoriesMoxibustion or warm-needle acupuncture only1424.6%Electroacupuncture only1119.3%Both modalities concurrently47.0% Frequency of Use of Moxibustion and Electroacupuncture Top 10 Acupoints for DLBP Treatment A total of 41 acupoints were identified across the 57 included studies, with an aggregate usage frequency of 337 instances. The ten most frequently selected acupoints are listed in Table 6. BL40 (Weizhong) ranked first (n=42, 12.5%), followed by BL25 (Dachangshu) (n=39, 11.6%), Ashi points (n=34, 10.1%), EX-B2 (Jiaji) (n=32, 9.5%), BL23 (Shenshu) (n=30, 8.9%), GV3 (Yaoyangguan) (n=23, 6.8%), GB30 (Huantiao) (n=17, 5.0%), ST36 (Zusanli) (n=10, 3.0%), and BL37 (Yinmen) and GB34 (Yanglingquan) (each n=8, 2.4%). Collectively, these top 10 acupoints accounted for 243 of the 337 total selections (72.1%). Table 6High-Frequency Acupoints Used in Acupuncture for DLBPRankAcupointFrequency (n)Frequency (%)MeridianSpecific Point Type1BL40 (Weizhong)4212.5%Foot Taiyang Bladder MeridianHe-Sea point, Lower He-Sea point2BL25 (Dachangshu)3911.6%Foot Taiyang Bladder MeridianBack-Shu point3Ashi point3410.1%Extra point—4EX-B2 (Jiaji)329.5%Extra point—5BL23 (Shenshu)308.9%Foot Taiyang Bladder MeridianBack-Shu point6GV3 (Yaoyangguan)236.8%Governor Vessel—7GB30 (Huantiao)175.0%Foot Shaoyang Gallbladder MeridianCrossing point8ST36 (Zusanli)103.0%Foot Yangming Stomach MeridianHe-Sea point, Lower He-Sea point9BL37 (Yinmen)82.4%Foot Taiyang Bladder Meridian—10GB34 (Yanglingquan)82.4%Foot Shaoyang Gallbladder MeridianHe-Sea point, Lower He-Sea point, Eight Meeting point Table 6High-Frequency Acupoints Used in Acupuncture for DLBPRankAcupointFrequency (n)Frequency (%)MeridianSpecific Point Type1BL40 (Weizhong)4212.5%Foot Taiyang Bladder MeridianHe-Sea point, Lower He-Sea point2BL25 (Dachangshu)3911.6%Foot Taiyang Bladder MeridianBack-Shu point3Ashi point3410.1%Extra point—4EX-B2 (Jiaji)329.5%Extra point—5BL23 (Shenshu)308.9%Foot Taiyang Bladder MeridianBack-Shu point6GV3 (Yaoyangguan)236.8%Governor Vessel—7GB30 (Huantiao)175.0%Foot Shaoyang Gallbladder MeridianCrossing point8ST36 (Zusanli)103.0%Foot Yangming Stomach MeridianHe-Sea point, Lower He-Sea point9BL37 (Yinmen)82.4%Foot Taiyang Bladder Meridian—10GB34 (Yanglingquan)82.4%Foot Shaoyang Gallbladder MeridianHe-Sea point, Lower He-Sea point, Eight Meeting point High-Frequency Acupoints Used in Acupuncture for DLBP Meridian Distribution of Acupoints The Foot Taiyang Bladder Meridian (BL) contributed the highest number of acupoints (n=16) and the greatest aggregate usage frequency (n=165, 49.0%), representing nearly half of all acupoint selections (Table 7). The Foot Shaoyang Gallbladder Meridian (GB) followed with 36 selections (10.7%), while extraordinary points (EX) and the Governor Vessel (GV) accounted for 38 (11.3%) and 35 (10.4%) selections, respectively. Among the twelve regular meridians, yang meridians including BL, GB, ST, SI, and GV collectively accounted for 248 selections (73.6%), whereas yin meridians including KI, SP, LR, and CV contributed 17 selections (5.0%). Ashi points though non-standardised were reported in 34 instances (10.1%). A radial network plot was constructed to visualize the meridian distribution patterns of acupuncture points and their corresponding usage frequencies (Figure 2). Table 7Meridian Distribution of Acupoints in DLBP Acupuncture PrescriptionsMeridianNumber of AcupointsPercentage of Acupoints (%)Frequency of UsePercentage of Use (%)Acupoints (Code)Foot Taiyang Bladder Meridian (BL)1639.0%16549.0%BL40 (Weizhong), BL37 (Yinmen), BL25 (Dachangshu), BL23 (Shenshu), BL57 (Chengshan), BL54 (Zhibian), BL32 (Ciliao), BL17 (Geshu), BL62 (Shenmai), BL26 (Guanyuanshu), BL28 (Pangguangshu), BL53 (Baohuang), BL60 (Kunlun), BL36 (Chengfu), BL20 (Pishu), BL52 (Zhishi)Extraordinary points (EX)49.8%3811.3%EX-B2 (Jiaji), EX-B7 (Yaoyi), EX-B8 (Yaoyan), EX-UE7 (Yaotongxue)Foot Shaoyang Gallbladder Meridian (GB)614.6%3610.7%GB35 (Yangjiao), GB30 (Huantiao), GB34 (Yanglingquan), GB36 (Waiqiu), GB31 (Fengshi), GB39 (Xuanzhong)Governor Vessel (GV)49.8%3510.4%GV3 (Yaoyangguan), GV2 (Yaoshu), GV4 (Mingmen), GV6 (Jizhong)Other12.4%3410.1%Ashi pointFoot Yangming Stomach Meridian (ST)12.4%103.0%ST36 (Zusanli)Foot Shaoyin Kidney Meridian (KI)37.3%82.4%KI3 (Taixi), KI4 (Dazhong), KI7 (Fuliu)Foot Taiyin Spleen Meridian (SP)24.9%51.5%SP6 (Sanyinjiao), SP10 (Xuehai)Conception Vessel (CV)24.9%30.9%CV6 (Qihai), CV4 (Guanyuan)Hand Taiyang Small Intestine Meridian (SI)12.4%20.6%SI3 (Houxi)Foot Jueyin Liver Meridian (LR)12.4%10.3%LR3 (Taichong) Figure 2Radial network plot of acupoint Meridian distribution.Radial network plot of acupoint Meridian distribution. The central node labeled ′Meridian′ connects to various acupoints. Acupoints are grouped by Meridian Group: Ashi, BL, CV, EX, GB, GV, KI, LR, SI, SP, ST. Each acupoint is labeled, such as BL40, BL37, BL25 and others. Frequency is indicated by circle size: medium, high, very high. The Foot Taiyang Bladder Meridian (BL) has the most connections, indicating high usage frequency. Other groups like GB, EX and GV are also connected, showing their respective acupoint distributions. The plot visualizes the distribution patterns and usage frequencies of acupuncture points across different meridians.Radial network plot of acupoint Meridian distribution with frequency and group labels. Table 7Meridian Distribution of Acupoints in DLBP Acupuncture PrescriptionsMeridianNumber of AcupointsPercentage of Acupoints (%)Frequency of UsePercentage of Use (%)Acupoints (Code)Foot Taiyang Bladder Meridian (BL)1639.0%16549.0%BL40 (Weizhong), BL37 (Yinmen), BL25 (Dachangshu), BL23 (Shenshu), BL57 (Chengshan), BL54 (Zhibian), BL32 (Ciliao), BL17 (Geshu), BL62 (Shenmai), BL26 (Guanyuanshu), BL28 (Pangguangshu), BL53 (Baohuang), BL60 (Kunlun), BL36 (Chengfu), BL20 (Pishu), BL52 (Zhishi)Extraordinary points (EX)49.8%3811.3%EX-B2 (Jiaji), EX-B7 (Yaoyi), EX-B8 (Yaoyan), EX-UE7 (Yaotongxue)Foot Shaoyang Gallbladder Meridian (GB)614.6%3610.7%GB35 (Yangjiao), GB30 (Huantiao), GB34 (Yanglingquan), GB36 (Waiqiu), GB31 (Fengshi), GB39 (Xuanzhong)Governor Vessel (GV)49.8%3510.4%GV3 (Yaoyangguan), GV2 (Yaoshu), GV4 (Mingmen), GV6 (Jizhong)Other12.4%3410.1%Ashi pointFoot Yangming Stomach Meridian (ST)12.4%103.0%ST36 (Zusanli)Foot Shaoyin Kidney Meridian (KI)37.3%82.4%KI3 (Taixi), KI4 (Dazhong), KI7 (Fuliu)Foot Taiyin Spleen Meridian (SP)24.9%51.5%SP6 (Sanyinjiao), SP10 (Xuehai)Conception Vessel (CV)24.9%30.9%CV6 (Qihai), CV4 (Guanyuan)Hand Taiyang Small Intestine Meridian (SI)12.4%20.6%SI3 (Houxi)Foot Jueyin Liver Meridian (LR)12.4%10.3%LR3 (Taichong) Meridian Distribution of Acupoints in DLBP Acupuncture Prescriptions Radial network plot of acupoint Meridian distribution. Application of Specific Acupoints Among the 41 acupoints identified, 24 (58.5%) were classified as specific points according to the WHO Standard Acupuncture Nomenclature (2008) and TCM classical definitions (Table 8). Seven acupoints exhibited multiple specific attributes collectively representing 12 distinct specific-point categories. Back-shu points were the most frequently applied specific-point type (n=85, 25.2%), followed by confluent points and he-sea points (each n=60, 17.8%). Crossing points were used in 27 instances (8.0%), while yuan-source points and shu-stream points each appeared in 9 instances (2.7%); all other specific-point categories occurred with lower frequency (<2% each). Table 8Frequency of Use of Specific Acupoints in DLBP TreatmentSpecific Point TypeNumber ofAcupointsAcupoints (Code and Frequency)Frequency (n)Percentage (%)Back-Shu points6BL25 (Dachangshu, 39), BL23 (Shenshu, 30), BL17 (Geshu, 4), BL26 (Guanyuanshu, 4), BL28 (Pangguangshu, 7), BL20 (Pishu, 1)8525.2%He-Sea points3BL40 (Weizhong, 42), GB34 (Yanglingquan, 8), ST36 (Zusanli, 10)6017.8%Lower He-Sea points3BL40 (Weizhong, 42), GB34 (Yanglingquan, 8), ST36 (Zusanli, 10)6017.8%Crossing points4GB30 (Huantiao, 17), SP6 (Sanyinjiao, 3), GV4 (Mingmen, 6), CV4 (Guanyuan, 1)278.0%Yuan-primary points3KI3 (Taixi, 6), LR3 (Taichong, 1), CV6 (Qihai, 2)92.7%Shu-Stream points3KI3 (Taixi, 6), LR3 (Taichong, 1), SI3 (Houxi, 2)92.7%Eight Meeting points2GB34 (Yanglingquan, 8), GB39 (Xuanzhong, 1)92.7%Xi-Cleft points2GB35 (Yangjiao, 7), GB36 (Waiqiu, 1)82.4%Jing-River points2BL60 (Kunlun, 4), KI7 (Fuliu, 1)51.5%Eight Confluent points2BL62 (Shenmai, 2), SI3 (Houxi, 2)41.2%Front-Mu points1CV4 (Guanyuan, 1)10.3%Luo-Connecting points1KI4 (Dazhong, 1)10.3%Notes: * He-Sea points and Lower He-Sea points are listed separately per the WHO standard; BL40, GB34, and ST36 satisfy both classifications. Table 8Frequency of Use of Specific Acupoints in DLBP TreatmentSpecific Point TypeNumber ofAcupointsAcupoints (Code and Frequency)Frequency (n)Percentage (%)Back-Shu points6BL25 (Dachangshu, 39), BL23 (Shenshu, 30), BL17 (Geshu, 4), BL26 (Guanyuanshu, 4), BL28 (Pangguangshu, 7), BL20 (Pishu, 1)8525.2%He-Sea points3BL40 (Weizhong, 42), GB34 (Yanglingquan, 8), ST36 (Zusanli, 10)6017.8%Lower He-Sea points3BL40 (Weizhong, 42), GB34 (Yanglingquan, 8), ST36 (Zusanli, 10)6017.8%Crossing points4GB30 (Huantiao, 17), SP6 (Sanyinjiao, 3), GV4 (Mingmen, 6), CV4 (Guanyuan, 1)278.0%Yuan-primary points3KI3 (Taixi, 6), LR3 (Taichong, 1), CV6 (Qihai, 2)92.7%Shu-Stream points3KI3 (Taixi, 6), LR3 (Taichong, 1), SI3 (Houxi, 2)92.7%Eight Meeting points2GB34 (Yanglingquan, 8), GB39 (Xuanzhong, 1)92.7%Xi-Cleft points2GB35 (Yangjiao, 7), GB36 (Waiqiu, 1)82.4%Jing-River points2BL60 (Kunlun, 4), KI7 (Fuliu, 1)51.5%Eight Confluent points2BL62 (Shenmai, 2), SI3 (Houxi, 2)41.2%Front-Mu points1CV4 (Guanyuan, 1)10.3%Luo-Connecting points1KI4 (Dazhong, 1)10.3%Notes: * He-Sea points and Lower He-Sea points are listed separately per the WHO standard; BL40, GB34, and ST36 satisfy both classifications. Frequency of Use of Specific Acupoints in DLBP Treatment Notes: * He-Sea points and Lower He-Sea points are listed separately per the WHO standard; BL40, GB34, and ST36 satisfy both classifications. Association Rule Analysis Association rule mining was performed using the Apriori algorithm on high-frequency acupoints extracted from the 57 included prescriptions, with minimum support and confidence thresholds set at 4% and 65%, respectively. A total of 455 statistically robust association rules met these criteria. The top 15 rules ranked by lift value are presented in Table 9. Compatibility relationships among acupoints are visualised in the network and scatter plots (Figures 3A and B): node size is proportional to individual acupoint usage frequency, and edge colour intensity (from yellow to red) reflects lift values, with warmer hues indicating stronger associative strength. Table 9Top 15 Association Rules for Acupoint Compatibility in DLBP Acupuncture PrescriptionsRankRule (Antecedent → Consequent)Support (%)Confidence (%)Lift1{BL37 (Yinmen), GB34 (Yanglingquan)} → {BL57 (Chengshan)}5.2675.010.692{SP6 (Sanyinjiao)} → {KI3 (Taixi)}5.261009.503{GV2 (Yaoshu)} → {GV4 (Mingmen)}7.021009.504{BL23 (Shenshu), SP6 (Sanyinjiao)} → {KI3 (Taixi)}5.261009.505{BL40 (Weizhong), SP6 (Sanyinjiao)} → {KI3 (Taixi)}5.261009.506{GV3 (Yaoyangguan), GV2 (Yaoshu)} → {GV4 (Mingmen)}7.021009.507{EX-B2 (Jiaji), GV2 (Yaoshu)} → {GV4 (Mingmen)}5.261009.508{BL23 (Shenshu), GV2 (Yaoshu)} → {GV4 (Mingmen)}7.021009.509{Ashi point, GV2 (Yaoshu)} → {GV4 (Mingmen)}5.261009.5010{BL40 (Weizhong), GV2 (Yaoshu)} → {GV4 (Mingmen)}7.021009.5011{GV4 (Mingmen)} → {GV2 (Yaoshu)}7.0266.79.5012{GV3 (Yaoyangguan), GV4 (Mingmen)} → {GV2 (Yaoshu)}7.0266.79.5013{BL23 (Shenshu), GV4 (Mingmen)} → {GV2 (Yaoshu)}7.0266.79.5014{BL40 (Weizhong), GV4 (Mingmen)} → {GV2 (Yaoshu)}7.0266.79.5015{BL54 (Zhibian), KI3 (Taixi)} → {BL32 (Ciliao)}5.261008.14 Figure 3(A) Network plot of association rules. (B) Scatter plot of association rules.Image A displays a network plot of acupoint association rules with nodes labeled by acupoint codes such as BL25, BL57, GB34 and others. Two main clusters are visible: one centered around BL57 with nearby nodes like GB34 and BL37 and another around GV2 and GV4 with connections to nodes like BL40 and KI3. A size legend indicates support levels with dot sizes from 0.06 to 0.12 and a lift scale from 6 to 10. Image B is a bubble scatter plot titled ′Items in LHS Groups.′ The x-axis represents lift, ranging from 6 to 10 and the y-axis shows RHS categories like (BL57) and (KI3). Bubbles are positioned at lift 6 for RHS (BL57), lift 7 for RHS (KI3) and so on, with a size legend for support values from 0.055 to 0.070.Network and scatter plots of acupoint association rules, highlighting clustered links and high-lift pairs. Table 9Top 15 Association Rules for Acupoint Compatibility in DLBP Acupuncture PrescriptionsRankRule (Antecedent → Consequent)Support (%)Confidence (%)Lift1{BL37 (Yinmen), GB34 (Yanglingquan)} → {BL57 (Chengshan)}5.2675.010.692{SP6 (Sanyinjiao)} → {KI3 (Taixi)}5.261009.503{GV2 (Yaoshu)} → {GV4 (Mingmen)}7.021009.504{BL23 (Shenshu), SP6 (Sanyinjiao)} → {KI3 (Taixi)}5.261009.505{BL40 (Weizhong), SP6 (Sanyinjiao)} → {KI3 (Taixi)}5.261009.506{GV3 (Yaoyangguan), GV2 (Yaoshu)} → {GV4 (Mingmen)}7.021009.507{EX-B2 (Jiaji), GV2 (Yaoshu)} → {GV4 (Mingmen)}5.261009.508{BL23 (Shenshu), GV2 (Yaoshu)} → {GV4 (Mingmen)}7.021009.509{Ashi point, GV2 (Yaoshu)} → {GV4 (Mingmen)}5.261009.5010{BL40 (Weizhong), GV2 (Yaoshu)} → {GV4 (Mingmen)}7.021009.5011{GV4 (Mingmen)} → {GV2 (Yaoshu)}7.0266.79.5012{GV3 (Yaoyangguan), GV4 (Mingmen)} → {GV2 (Yaoshu)}7.0266.79.5013{BL23 (Shenshu), GV4 (Mingmen)} → {GV2 (Yaoshu)}7.0266.79.5014{BL40 (Weizhong), GV4 (Mingmen)} → {GV2 (Yaoshu)}7.0266.79.5015{BL54 (Zhibian), KI3 (Taixi)} → {BL32 (Ciliao)}5.261008.14 Top 15 Association Rules for Acupoint Compatibility in DLBP Acupuncture Prescriptions (A) Network plot of association rules. (B) Scatter plot of association rules. Cluster Analysis Hierarchical cluster analysis was performed on all 41 acupoints identified across the 57 included studies. The resulting dendrogram (Figure 4) displays all 41 acupoints, reflecting their pairwise dissimilarities based on co-occurrence patterns. Applying a squared Euclidean distance cutoff of 15 chosen to balance cluster stability and clinical interpretability three robust and clinically meaningful clusters were identified, collectively encompassing 21 acupoints: Cluster 1 (C1) comprised six acupoints BL37 (Yinmen), GB35 (Yangjiao), GB30 (Huantiao), GB34 (Yanglingquan), ST36 (Zusanli), and BL57 (Chengshan); Cluster 2 (C2) included six acupoints EX-B2 (Jiaji), GV3 (Yaoyangguan), BL25 (Dachangshu), BL23 (Shenshu), Ashi points, and BL40 (Weizhong); and Cluster 3 (C3) consisted of nine acupoints GV4 (Mingmen), BL28 (Pangguangshu), BL54 (Zhibian), BL17 (Geshu), BL32 (Ciliao), BL60 (Kunlun), GV2 (Yaoshu), BL26 (Guanyuanshu), and KI3 (Taixi). The remaining 20 acupoints did not form stable clusters at this threshold and were therefore not assigned to any of the three primary clusters or reported as distinct clusters. Figure 5 displays the cluster heatmap, illustrating co-occurrence frequencies across the 57 prescriptions and 41 acupoints, with colour intensity (red gradient) quantitatively representing the number of prescriptions in which each acupoint pair appeared together. Figure 4Dendrogram of hierarchical clustering.Dendrogram of core acupoint clustering for DLBP with three clusters. Cluster 1, the Distal-Meridian Group, is outlined in red and includes acupoints GB34, BL57, GB30, BL37, GB35 and ST36. Cluster 2, the Lumbar-Local Group, is outlined in blue and includes acupoints EX-B2, GV3, BL25, BL23, Ashi and BL40. Cluster 3, the Syndrome-Based Group, is outlined in green and includes acupoints GV2, GV4, BL26, BL28, KI3, BL54, BL32, BL17 and BL60. The vertical axis represents binary distance, ranging from 0.2 to 1.6, indicating the dissimilarity between acupoints. The horizontal axis lists the acupoint codes. The dendrogram visually represents the hierarchical clustering of acupoints based on their co-occurrence patterns.Dendrogram showing core acupoint clustering for DLBP. Figure 5Heatmap of clustering of 41 acupoints based on all data.The heatmap displays clustering of 41 acupoints with dendrograms above columns and beside rows. Acupoint codes like GV6, BL20 and others label the horizontal axis, while numeric identifiers from 1 to 57 label the vertical axis. A legend on the right shows a gradient scale from 0 to 1, where filled cells represent higher values. The matrix is mostly sparse, with a prominent cluster forming a dense band of filled cells in the middle columns and smaller clusters in other areas. Scattered filled cells indicate occasional higher values outside the main clusters.Clustering heatmap of 41 acupoints with dendrograms, acupoint row and column labels, no cell numbers. Dendrogram of hierarchical clustering. Heatmap of clustering of 41 acupoints based on all data. Discussion Main Findings As the first data-mining study specifically focused on DLBP distinct from LDH, this analysis identified acupoint selection patterns markedly divergent from those reported in LDH-focused literature. We systematically reviewed and synthesised evidence from 57 randomised or non-randomised clinical studies evaluating acupuncture for DLBP, extracting and analysing acupoint selection patterns, compatibility profiles, and treatment parameter specifications. The most frequently selected acupoints were BL40 (Weizhong, 12.5%), BL25 (Dachangshu, 11.6%), Ashi points (10.1%), EX-B2 (Jiaji, 9.5%), and BL23 (Shenshu, 8.9%). Collectively, the top 10 acupoints accounted for 243 of 337 total selections (72.1%), indicating a high degree of consensus and concentration in clinical practice. The Foot Taiyang Bladder Meridian was the predominant channel, contributing 16 acupoints and 165 selections (49.0%); the Foot Shaoyang Gallbladder Meridian (36 selections, 10.7%), Governor Vessel (35 selections, 10.4%), and extraordinary points (38 selections, 11.3%) followed in frequency. Among specific-point categories, back-shu points were most prevalent (n=85, 25.2%), followed by confluent points and he-sea points (each n=60, 17.8%). Regarding treatment parameters, needle retention time was most commonly 30 minutes (n=33, 60.0%), treatment frequency was predominantly once daily (n=37, 64.9%), and total course length most often comprised 14 sessions (n=10, 18.2%). Additional modality utilisation included long needles (≥50 mm) in 34.6% of studies, warm-needle acupuncture or moxibustion in 31.6%, and electroacupuncture in 26.3%. Collectively, these empirically derived patterns provide a robust, evidence-informed foundation for developing standardised, diagnosis-specific acupuncture protocols for DLBP. As a data-mining study grounded in acupoint usage frequency and co-occurrence patterns not experimental manipulation or controlled causal inference our findings reveal associative patterns rather than causal relationships. The mechanistic and TCM-based interpretations presented in the Discussion are therefore inherently exploratory and hypothesis-generating; they reflect plausible theoretical alignments between observed clinical practice patterns and established pathophysiological frameworks, but do not constitute empirical confirmation. Rigorous prospective validation through randomized controlled trials, neuroimaging studies, or targeted physiological assays is required to test these hypotheses and establish causal or biological plausibility. Moreover, this study elucidated acupoint compatibility patterns and core prescription configurations through association rule mining and hierarchical cluster analysis, thereby providing empirically grounded evidence to inform the refinement of clinical acupuncture protocols for DLBP. Association Rule Analysis The association rule exhibiting the highest lift value was {BL37 (Yinmen), GB34 (Yanglingquan)} → {BL57 (Chengshan)} (lift = 10.69), indicating a robust synergistic compatibility among lower-limb acupoints primarily aimed at regulating qi flow in the Foot Taiyang Bladder and Foot Shaoyang Gallbladder Meridians. Notably, multiple rules involving Governor Vessel points including GV2 (Yaoshu), GV3 (Yaoyangguan), and GV4 (Mingmen) achieved consistently high lift values (9.50) and perfect confidence (100%), revealing a highly stable, fixed compatibility pattern within the Governor Vessel. This pattern reflects the core therapeutic strategy of “warming and unblocking the Du Meridian” in DLBP management. Similarly, the rule {SP6 (Sanyinjiao)} → {KI3 (Taixi)} (lift = 9.50, confidence = 100%) indicates strong synergistic engagement of the Spleen and Kidney Meridians, aligning with the root-treatment principle of “strengthening the Spleen and nourishing the Kidney”. Furthermore, {Ashi point, GV2 (Yaoshu)} → {GV4 (Mingmen)} (lift = 9.50) illustrates the integrated application of local tender points and key Du Meridian warming points embodying the holistic principle of “treating both root (ben) and branch (biao)”. Cluster Analysis: Core Prescriptions and Treatment Strategies This study employed two complementary clustering visualization approaches to characterize acupoint compatibility patterns in DLBP acupuncture prescriptions from complementary analytical perspectives. The hierarchical dendrogram (Figure 4) delineates the micro-level structural relationships among high-frequency acupoints, revealing their natural grouping based on co-occurrence similarity. In contrast, the prescription–acupoint heatmap (Figure 5) captures the macro-level association density across all 57 prescriptions and 41 acupoints, quantifying how frequently each acupoint pair appears together. These two methods provide mutually reinforcing evidence, collectively supporting three clinically coherent acupoint selection strategies for DLBP. Consistent with the Bladder Meridian’s anatomical course along the posterior midline in classical meridian theory, the heatmap shows that Bladder Meridian points (eg, BL23, BL25, BL40) exhibit the highest co-occurrence frequency across prescriptions. Moreover, prominent red clusters corresponding to Ashi points and EX-B2 (Jiaji) underscore the centrality of precise local stimulation in DLBP management, embodying the clinical principle “where there is pain, there is the point” (“tong ze bu tong”, ie, treating local obstruction). Conversely, distal points including ST36 (Zusanli) and KI3 (Taixi) display more dispersed distribution patterns in the heatmap, suggesting their role as syndrome-specific modifiers rather than core components. The dendrogram further partitions the 41 high-frequency acupoints into three statistically stable clusters, each reflecting a distinct therapeutic rationale: Cluster 1 (“Distal Regulation Group”) comprises predominantly lower-limb acupoints (eg, GB34, BL37, ST36) that modulate qi and blood circulation in the Foot Taiyang and Foot Shaoyang Meridians via distal stimulation; Cluster 2 (“Local Lumbar Group”) centers on pathological local points (eg, BL23, BL25, BL40, Ashi, EX-B2), directly addressing stagnation of qi and blood in the lumbosacral region; and Cluster 3 (“Syndrome-Differentiation Group”) integrates Du Meridian (eg, GV2, GV4) and Kidney Meridian (eg, KI3, BL23) points, enabling individualized prescription tailoring according to TCM pattern diagnosis including kidney deficiency, blood stasis, or cold-damp obstruction. This tripartite classification aligns rigorously with the foundational TCM paradigm of “integrating disease location and pathogenesis” (bing wei yu bing ji jie he) in pattern-based treatment. Critically, cross-method validation strengthens confidence in these findings: the most frequently used acupoints in the heatmap (eg, BL23, BL40, Ashi) consistently constitute the core members of Cluster 2 in the dendrogram, whereas medium-frequency points (eg, KI3, ST36) are robustly assigned to Cluster 3. This concordance across independent analytical frameworks supports the stability and biological plausibility of the identified clustering structure. Comparative Analysis of DLBP and LDH Although both DLBP and LDH fall under the broader clinical category of low back pain, their underlying pathophysiological mechanisms are fundamentally distinct differences that directly inform divergent acupuncture treatment strategies. To clarify the diagnostic specificity of acupoint selection in DLBP, we conducted a systematic comparative analysis against the large-scale data-mining study on LDH by Zheng et al,17 which synthesised evidence from 537 studies and 766 prescriptions. Importantly, this cross-diagnosis comparison is based on independent datasets (our DLBP cohort versus Zheng et al’s LDH dataset), and methodological variations including differences in inclusion criteria, acupoint coding standards, and analytical thresholds preclude direct quantitative equivalence. Consequently, the observed patterns reflect robust directional trends rather than statistically comparable effect estimates. Pathophysiological Distinctions The core pathophysiology of discogenic low back pain (DLBP) centers on intradiscal inflammatory cascades triggered by intervertebral disc degeneration, annular fissures, and vertebral endplate disruption distinct from mechanical nerve root compression. Epidemiological data indicate that DLBP affects 26–42% of cases among patients with chronic low back pain, rendering it the most prevalent subtype of chronic low back pain and accounting for approximately 40% of all chronic low back pain cases.3 Disc tissue harvested from DLBP patients demonstrates markedly elevated expression of pro-inflammatory mediators including interleukin-6 (IL-6), IL-8, tumor necrosis factor-alpha (TNF-α), and prostaglandin E2 (PGE2) suggesting that intradiscal synthesis of these molecules constitutes a primary driver of nociception in DLBP.18 Supporting this, Burke et al19 reported significantly higher secretion levels of IL-6 (p < 0.006) and IL-8 (p < 0.003) in disc samples from DLBP patients compared with those from LDH patients, consistent with an inflammation-dominant phenotype in DLBP. Further mechanistic insight was provided by Hamamoto et al,20 who employed a rat caudal disc compression model to demonstrate that macrophage infiltration into symptomatic degenerated discs is a critical initiating event in establishing the DLBP-specific inflammatory microenvironment; co-culture of degenerated human disc tissue with macrophages resulted in significantly augmented production of PGE2 and IL-6. In contrast, LDH-associated pain arises from a dual-pathway mechanism involving both mechanical compression and neuroinflammatory processes. As comprehensively reviewed by Cosamalón-Gan et al,21 disc tissue from LDH patients exhibits heightened biological activity and robust expression of multiple inflammatory mediators including IL-1β, IL-6, IL-8, and TNF-α which not only directly sensitize adjacent nerve roots to generate ectopic discharges but also promote central sensitization via macrophage recruitment into the dorsal root ganglia (DRG) and microglial activation within the spinal dorsal horn.22 Consequently, DLBP manifests as a non-radicular, discogenic referred pain localized predominantly to the lower back and buttocks with radiation, if present, typically confined to the proximal thigh whereas LDH produces radicular pain that follows a dermatomal distribution, often accompanied by objective neurological deficits such as sensory impairment and muscle weakness.23 From the perspective of Traditional Chinese Medicine (TCM) pattern differentiation, the distribution of diagnostic patterns in DLBP and LDH exhibits marked divergence. Ma et al24 conducted a TCM pattern survey among 275 DLBP patients and identified cold-damp obstruction as the predominant pattern (36.4%), followed by qi stagnation and blood stasis (20.4%) and spleen-kidney yang deficiency (18.2%). This clinical pattern distribution aligns closely with the contemporary understanding of DLBP pathophysiology: the chronic, low-grade intradiscal inflammatory milieu characterized by persistent cytokine release and tissue edema corresponds conceptually to the TCM pathogenic factors of “cold” and “dampness”, whose inherent qualities of stagnation, heaviness, and tenacity mirror the insidious progression and refractory nature of discogenic inflammation.25 In contrast, LDH is fundamentally characterized by mechanical compression of neural structures secondary to disc herniation, resulting in localized disruption of qi and blood circulation. Its core TCM pathogenesis is therefore centered on “qi stagnation and blood stasis”. Consistent with this, Zheng et al’s data-mining analysis of 766 LDH acupuncture prescriptions revealed significantly higher utilization of distal Gallbladder Meridian points including GB30 (Huantiao) and GB34 (Yanglingquan) in LDH compared with DLBP,17 notably, warming interventions (eg, warm-needle acupuncture or moxibustion) were infrequently reported. This acupoint selection strategy reflects the clinical imperative to unblock meridian flow along the sciatic nerve pathway: disc herniation compresses the sciatic nerve root, producing radiating pain that follows the Gallbladder Meridian’s anatomical course, thereby justifying the emphasis on distal regulatory points. Furthermore, the perineural inflammatory and fibrotic microenvironment surrounding the compressed nerve root corresponds to the TCM pattern of “qi stagnation and blood stasis”. Supporting this interpretation, Wang et al26 classified LDH patterns into categories including Du Meridian blood stasis and Gallbladder Meridian damp-heat. Clinical trials have further demonstrated the efficacy of blood-activating and stasis-resolving interventions such as Shentong Zhuyu Tang in LDH management; this therapeutic response, interpreted through the principle of “pattern verification via treatment” (zhi fa fan zheng) is consistent with the centrality of the blood stasis pattern in LDH pathogenesis.27 Collectively, these findings underscore a fundamental pathophysiological distinction: DLBP arises primarily from intra-discal inflammation manifesting clinically as cold-damp obstruction, whereas LDH stems from nerve root compression manifesting as qi stagnation and blood stasis. In summary, DLBP is pathophysiologically defined by intra-discal inflammation and clinically characterised in TCM by the predominance of cold-damp obstruction. This provides a coherent theoretical rationale for the relatively high utilisation of warming interventions, such as warm-needle acupuncture and moxibustion (31.6%), in its management. In contrast, LDH is fundamentally driven by mechanical nerve root compression compounded by perineural chemical irritation, manifesting predominantly as qi stagnation and blood stasis in TCM pattern differentiation. This fundamental divergence in underlying pathophysiology namely, intra-discal inflammatory dysregulation versus neuro-mechanical compression with secondary neuroinflammation provides a plausible mechanistic framework for understanding the observed differences in acupuncture point selection strategies between the two conditions. Differences in Acupoint Selection The pathophysiological distinctions outlined above are directly mirrored in clinical acupoint selection patterns. As summarised in Table 10, DLBP and LDH exhibit systematic differences across three key dimensions: (i) predominant meridians engaged, (ii) high-frequency acupoints, and (iii) underlying therapeutic strategies. Table 10Comparison of Acupoint Selection Patterns Between DLBP and LDHComparison DimensionDLBP (Present Study)LDH (Zheng et al17)Core meridianFoot Taiyang Bladder Meridian (49.0%)Foot Taiyang Bladder Meridian (57.7%)Most frequent acupointBL40 (Weizhong, 12.5%)BL40 (Weizhong, 9.7%)Second most frequent acupointBL25 (Dachangshu, 11.6%)GB30 (Huantiao, 8.5%)Rank of Ashi points3rd (10.1%)7th (5.0%)Rank of EX-B2 (Jiaji)4th (9.5%)5th (7.8%)Utilisation rate of GV3 (Yaoyangguan)6.8%3.9%Utilisation rate of GB30 (Huantiao)5.0%8.5%Utilisation rate of GB34 (Yanglingquan)2.4%6.4%Preference for warming methodsWarm-needle acupuncture/moxibustion: 31.6%Not prominently reportedClustering strategyThree groups: distal regulation, local lumbar, syndrome differentiationBladder Meridian core formula + Gallbladder Meridian strategy Table 10Comparison of Acupoint Selection Patterns Between DLBP and LDHComparison DimensionDLBP (Present Study)LDH (Zheng et al17)Core meridianFoot Taiyang Bladder Meridian (49.0%)Foot Taiyang Bladder Meridian (57.7%)Most frequent acupointBL40 (Weizhong, 12.5%)BL40 (Weizhong, 9.7%)Second most frequent acupointBL25 (Dachangshu, 11.6%)GB30 (Huantiao, 8.5%)Rank of Ashi points3rd (10.1%)7th (5.0%)Rank of EX-B2 (Jiaji)4th (9.5%)5th (7.8%)Utilisation rate of GV3 (Yaoyangguan)6.8%3.9%Utilisation rate of GB30 (Huantiao)5.0%8.5%Utilisation rate of GB34 (Yanglingquan)2.4%6.4%Preference for warming methodsWarm-needle acupuncture/moxibustion: 31.6%Not prominently reportedClustering strategyThree groups: distal regulation, local lumbar, syndrome differentiationBladder Meridian core formula + Gallbladder Meridian strategy Comparison of Acupoint Selection Patterns Between DLBP and LDH Difference 1: Enhanced Utilisation of Ashi Points and EX-B2 (Jiaji) for Precise Local Targeting In this study, Ashi points and EX-B2 (Jiaji) were among the most frequently selected acupoints for DLBP, ranking third (10.1%) and fourth (9.5%) respectively. This contrasts with their reported usage in LDH, where Ashi points and Jiaji points were employed less frequently, ranking seventh 5.0%) and fifth (7.8%) in a separate large-scale analysis. The pathological rationale for this disparity lies in the distinct origins of pain: DLBP pain stems from diffuse inflammation and nociceptor sensitisation within the disc due to annular tears, resulting in poorly localised discomfort that necessitates the identification of Ashi points to target exact pathological loci. Conversely, LDH pain is typically radicular, following clear neuroanatomical pathways due to nerve root compression; consequently, treatment strategies rely more heavily on selecting points along the affected meridians to alleviate the compression and its radiating symptoms. Difference 2: Enhanced Utilisation of Du Meridian Points for Warming and Regulating Yang Qi In this study, GV3 (Yaoyangguan) ranked sixth among all acupoints selected for DLBP, accounting for 6.9% of total acupoint selections. Although GV4 (Mingmen) did not appear within the top ten most frequently selected acupoints (n=6,1.8%), it demonstrated robust associative relationships with other Governor Vessel points in the association rule analysis (Table 9, rules 3, 6–10, 12–15; lift = 9.50). In contrast, in the comparative LDH analysis, GV3 was utilised at a markedly lower frequency (3.9%), and GV4 did not appear within the top ten most frequently used points. This differential pattern aligns directly with the TCM pathogenesis of cold-damp obstruction in DLBP. As pivotal points on the Du Meridian the “Sea of the Yang Meridians” both Yaoyangguan and Mingmen are classically indicated to warm the yang qi of the lower back, dispel cold-damp pathogens, and restore unimpeded flow of qi and blood along the governing channel. Their heightened usage in DLBP thus reflects a targeted therapeutic strategy that addresses the core pathological mechanism at its source. Difference 3: Reduced Utilisation of Gallbladder Meridian Points Reflecting the Absence of Classic Radicular Pain In this study, GB30 (Huantiao) and GB34 (Yanglingquan) ranked seventh (5.0%) and tenth (2.4%), respectively, among acupoints selected for DLBP. In contrast, in the comparative LDH analysis, GB30 ranked second (8.5%) and GB34 ranked sixth (6.7%). This marked disparity reflects a fundamental clinical distinction: LDH is characterised by classic radicular pain typically radiating along the sciatic nerve distribution due to mechanical compression and neuroinflammatory irritation necessitating the use of distal Gallbladder Meridian points to regulate meridian qi flow and alleviate referred symptoms. DLBP, however, presents predominantly as localised or poorly localised low back pain; radiating discomfort, when present, is typically confined to the gluteal region and proximal thigh without extending into the distal leg or foot. Consequently, the therapeutic emphasis shifts away from distal meridian regulation toward local and axial interventions. This differential pattern further supports the diagnostic fidelity of the included DLBP studies, indicating strict adherence to established clinical criteria and minimal risk of inadvertent inclusion of LDH patients. As visualised in the radar chart (Figure 6), the high-frequency acupoint distribution diverges distinctly: DLBP prescriptions concentrate heavily on lumbar-local points including Ashi points, EX-B2 (Jiaji), and GV3 (Yaoyangguan) whereas LDH prescriptions show pronounced clustering on lower-limb points, particularly GB30 (Huantiao) and GB34 (Yanglingquan). Figure 6Radar chart of high frequency acupoint differences.Radar chart showing acupuncture feature comparison between DLBP and LDH. Radar chart of high frequency acupoint differences. Difference 4: Predominant Application of Warming Interventions Aligned with the Principle of “Treating Cold with Heat” In this study, warming interventions including warm-needle acupuncture and moxibustion were applied in 31.6% of DLBP cases, representing the highest utilisation rate among all therapeutic modalities. This high prevalence directly embodies the TCM therapeutic principle of “treating cold with heat” (han zhe re zhi), providing empirical support for the pathogenic classification of DLBP as a cold-damp obstruction syndrome. In contrast, LDH management places greater emphasis on blood-activating and stasis-resolving strategies, reflecting its core pathogenesis of qi stagnation and blood stasis. The marked divergence in modality preference thus reinforces the distinct TCM pattern differentiation between the two conditions. Shared Acupunctural Foundations Despite the aforementioned pathophysiological and pattern-differentiation distinctions, DLBP and LDH share several foundational principles in acupoint selection. The Foot Taiyang Bladder Meridian serves as the principal meridian for both conditions, with BL40 (Weizhong) consistently ranking first in frequency across both cohorts consistent with the classical TCM principle “for low back pain, seek Weizhong” (yao tong qu wei zhong). Similarly, back-shu points including BL25 (Dachangshu) and BL23 (Shenshu) are employed with notable frequency in both diseases, exemplifying the fundamental local treatment strategy “where the point is located, there lies its indication” (a shi chu ji shi chu). These shared patterns underscore the anatomical and functional centrality of the lumbar region and its associated meridian networks in the management of chronic low back pain, irrespective of underlying aetiology. Summary In conclusion, while DLBP and LDH share foundational acupoint selection principles most notably the centrality of the Foot Taiyang Bladder Meridian and the consistent top-ranking frequency of BL40 (Weizhong) they diverge markedly in their targeted therapeutic strategies. DLBP management prioritises precise local intervention, reflected in the high utilisation of Ashi points and EX-B2 (Jiaji), alongside warming modalities including Du Meridian points (eg, GV3, GV4) and warm-needle acupuncture or moxibustion to directly address its core TCM pathogenesis of cold-damp obstruction. In contrast, LDH treatment emphasises distal meridian regulation, particularly via Gallbladder Meridian points such as GB30 (Huantiao) and GB34 (Yanglingquan), combined with blood-activating and meridian-unblocking approaches to resolve the qi stagnation and blood stasis arising from mechanical nerve root compression. This “common foundation with pattern-specific differentiation” in acupoint selection is not empirical convention but a direct clinical manifestation of the distinct underlying pathophysiologies; it thereby provides a useful framework for precision treatment grounded in TCM pattern differentiation. Multilevel Neurobiological Mechanisms of Acupuncture Analgesia Underpin Acupoint Selection Strategies The biological basis for the aforementioned differences in pathogenesis and acupoint selection between DLBP and LDH can be elucidated through the framework of multilevel acupuncture analgesia mechanisms. In recent years, foundational research and neuroimaging studies have substantiated the scientific basis of acupuncture analgesia across multiple tiers, encompassing the peripheral, spinal, cerebral cortical, and neuroimmune interaction levels.15 Peripheral Level Acupuncture stimulation initiates a cascade of local biological responses. Evidence demonstrates that needle insertion significantly downregulates pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 in perilesional tissues, while concurrently upregulating anti-inflammatory mediators such as IL-10 and TGF-β, thereby directly suppressing the local inflammatory cascade at the site of nociception.28,29 A systematic review by Li et al further underscores the centrality of peripheral immune modulation and neuroimmune crosstalk on primary nociceptors in acupuncture’s analgesic effect against inflammatory pain.30 Mechanistically, acupuncture inhibits key pro-inflammatory signalling pathways namely JAK2/STAT3 and PI3K/mTOR and modulates glial cell activity by downregulating the microglial chemokine receptor CX3CR1 and upregulating the astrocytic adenosine A1 receptor (A1R), collectively attenuating neuroinflammation and glial activation.31 These well-documented peripheral mechanisms provide a robust biological rationale for the preferential use of local acupoints including Ashi points and EX-B2 (Jiaji) in DLBP management: the needle acts directly on the superficial and deep fascial layers surrounding the intervertebral disc, enabling targeted, lesion-proximal anti-inflammatory intervention. Spinal Level Acupuncture exerts potent inhibitory effects on nociceptive signal transmission at the spinal level. Chen et al demonstrated that acupuncture downregulates the expression of key excitatory neurotransmitters and receptors including glutamate, NMDA receptors, P2X receptors, substance P (SP), and calcitonin gene-related peptide (CGRP) within the spinal dorsal horn, thereby attenuating ascending nociceptive input from peripheral afferents.31,32 In a rat incisional neck pain model, Lu et al further showed that electroacupuncture at LI18 (Futu) or the distal combination of LI4 (Hegu) and PC6 (Neiguan) significantly upregulates GABA and its receptor subunits (GABA-Aα2, GABA-Aβ3, GABA-B1, GABA-B2) in the spinal dorsal horn; critically, this analgesic effect was abolished by selective GABA-A and GABA-B receptor antagonists, providing direct pharmacological evidence for GABAergic mediation.33 Concurrently, acupuncture activates endogenous descending inhibitory pathways evidenced by increased release of β-endorphin and enhanced expression of GABA and its receptors thereby reinforcing spinal gate control and suppressing pain transmission.34 These convergent mechanisms collectively underpin the clinical rationale for distal acupoint selection in DLBP management (eg, BL37 Yinmen, ST36 Zusanli): stimulation of these points engages supraspinal–spinal circuitry to modulate lumbosacral nociception indirectly, extending therapeutic influence beyond the local site. Central (Cortico-Brainstem) Level Contemporary neuroimaging research has established that acupuncture modulates functional networks within the central nervous system that are integral to pain processing and regulation. A systematic review by Wen et al synthesised evidence from neuroimaging studies in low back pain, demonstrating that acupuncture consistently modulates neural activity in key regions of the “pain matrix” including the insula, anterior cingulate cortex (ACC), primary somatosensory cortex (S1), and cerebellum thereby contributing to its analgesic effect.35 These regions are functionally embedded within canonical large-scale brain networks: the default mode network (DMN), salience network (SN), sensorimotor network, and descending pain modulation system (DPMS). Otti et al further reported that acupuncture strengthens functional connectivity between the DMN and critical subcortical and limbic nodes including the periaqueductal grey (PAG), ACC, amygdala, and hippocampus suggesting a mechanism for restoring psychophysiological homeostasis disrupted by chronic pain.36 In patients with chronic low back pain, Makary et al observed that acupuncture enhances resting-state functional connectivity specifically between the PAG (a pivotal brainstem hub of endogenous descending inhibition) and the amygdala (a limbic structure implicated in pain-related affective processing), with this connectivity change significantly correlating with clinical pain reduction.37 Complementing these findings, a high-quality systematic review by Kelly et al38 incorporating eight fMRI studies (six rated as high quality, two as fair quality) identified robust acupuncture-induced alterations in functional connectivity across the salience, sensorimotor, DMN, and limbic networks.39 Collectively, these convergent neuroimaging data provide direct, in vivo evidence that acupuncture alleviates chronic low back pain by potentiating endogenous analgesic circuitry, particularly through cortico-brainstem interactions. Summary In summary, acupuncture analgesia operates through a highly integrated, multilevel neurobiological cascade spanning peripheral nociceptor modulation, spinal gate control, and cortico-brainstem regulatory networks constituting a paradigmatic “multi-target, multi-level” analgesic mechanism.39 DLBP is characterised by intradiscal inflammatory pain underpinned by the TCM pattern of cold-damp obstruction; consequently, its acupuncture management strategically integrates three complementary components: (i) precise local intervention via Ashi points and EX-B2 (Jiaji) to directly suppress peridiscal inflammation; (ii) Du Meridian warming points including GV3 (Yaoyangguan) and GV4 (Mingmen) to dispel cold-damp pathogens and restore yang qi in the lumbar region; and (iii) distal regulatory points leveraging synergistic actions across the Bladder and Gallbladder Meridians to engage descending inhibitory pathways. This tripartite strategy simultaneously harnesses acupuncture’s peripheral anti-inflammatory effects and its central neuromodulatory capacity thereby achieving targeted lesion suppression and systemic restoration of pain homeostasis. Limitations and Future Directions This study has several methodological limitations. First, the included literature exhibits heterogeneity in study design and methodological rigour; a substantial proportion comprises non-randomised clinical observations rather than randomised controlled trials (RCTs), potentially compromising the internal validity of pooled findings. Second, incomplete reporting of treatment parameters including needle retention time, gauge, length, and manipulation technique precluded their inclusion in quantitative synthesis, thereby reducing analytical power for dose-related assessments. Third, considerable variability exists across acupuncture prescriptions in terms of needling depth, de qi quality, stimulation modality (manual vs electroacupuncture), treatment frequency, and course duration; due to insufficient granularity in primary reports, stratified analyses by these clinically relevant factors were not feasible. Fourth, the limited number of eligible studies constrained our capacity to conduct sensitivity analyses or subgroup analyses such as those stratified by risk of bias or study quality to assess result robustness. Fifth, the restriction to Chinese- and English-language publications introduces potential language bias, possibly omitting relevant evidence from other linguistic regions, which may limit the generalisability of our findings to acupuncture practices reported in other languages. Future research should prioritise the following directions: (1) conducting high-quality, adequately powered RCTs to prospectively validate the clinical efficacy and safety of the core acupoint combinations and standardised parameter protocols identified herein; (2) systematically investigating the dose–response relationships in DLBP acupuncture, including optimal needle depth, electroacupuncture parameters (eg, frequency, intensity, waveform), and treatment course duration; (3) employing multimodal neuroimaging including task-based and resting-state fMRI, functional connectivity analysis, and neurochemical spectroscopy to elucidate central neural mechanisms underlying acupuncture analgesia in DLBP; (4) performing pattern-stratified comparative studies to delineate distinct acupoint selection rules across TCM syndromes of DLBP (eg, cold-damp obstruction, liver-kidney deficiency, qi stagnation and blood stasis), thereby advancing precision pattern-based treatment; and (5) integrating data-mining–derived acupoint networks with systems biology approaches such as network pharmacology, transcriptomics, and metabolomics to uncover molecular and pathway-level mechanisms mediating acupuncture’s therapeutic effects in DLBP. Emerging evidence further underscores the pathophysiological relevance of Modic 1–associated vertebral endplate changes in discogenic low back pain (DLBP), and minimally invasive anti-inflammatory interventions such as intradiscal oxygen–ozone therapy have demonstrated preliminary efficacy in modulating discogenic pain phenotypes (Fiaschetti et al, 2026).40 Prospective investigations that systematically integrate these modalities with acupuncture-based strategies hold promise for refining evidence-informed, multimodal approaches to DLBP management. Conclusions Given the exploratory, hypothesis-generating nature of this data-mining study, the identified acupoint patterns require prospective validation through rigorously designed, adequately powered randomized controlled trials and mechanistic studies before they can be considered for integration into standardized clinical protocols. This study represents the first systematic investigation into acupoint selection patterns and treatment parameters for acupuncture in the management of DLBP. The principal findings are summarised as follows. First, core acupoint selection patterns. The five most frequently used acupoints were BL40 (Weizhong; 12.5%), BL25 (Dachangshu; 11.6%), Ashi points (10.1%), EX-B2 (Jiaji; 9.5%), and BL23 (Shenshu; 8.9%). Collectively, the top ten acupoints accounted for 72.1% of all acupoint usages, reflecting a high degree of clinical consensus and concentration in point selection. The Foot Taiyang Bladder Meridian was the predominant meridian (165 usages, 49.0%), followed by the Foot Shaoyang Gallbladder Meridian, Du Meridian (Governor Vessel), and extraordinary points. Second, treatment parameter characteristics. Standardised clinical parameters identified in this analysis include a needle retention time of 30 minutes, a treatment frequency of once daily, and a total course duration most commonly structured as either a short course (6–15 sessions; 45.6%) or a long course (28–40 sessions; 25.5%), with 14 sessions representing the single most prevalent course length (18.2%). The most frequently employed needle specification was 0.30 mm × 40 mm (42.3%). Warm-needle acupuncture and moxibustion were utilised in 31.6% of cases, while long needles (≥50 mm) were applied in 34.6% both modalities aligning with the TCM pathophysiological features of DLBP, namely deep-seated lesion location and cold-damp obstruction. Third, core acupoint compatibility patterns. Association rule mining yielded 455 statistically robust association rules (minimum support ≥4%, minimum confidence ≥65%). Key compatibility patterns include: (i) intra-Du Meridian pairing (GV2 → GV4; lift = 9.50), operationalising the therapeutic principle of “warming and unblocking the Du Meridian”; (ii) lower-limb synergistic pairing (BL37 + GB34 → BL57; lift = 10.69), reflecting coordinated regulation of the Bladder and Gallbladder Meridians to restore qi flow in the lower extremities; and (iii) Spleen–Kidney Meridian coupling (SP6 → KI3; lift = 9.50), embodying the root-treatment strategy of “strengthening the Spleen and nourishing the Kidney” to address constitutional deficiency underlying chronic low back pain. Fourth, three therapeutic strategies revealed by cluster analysis. Hierarchical clustering grouped frequently used acupuncture points into three stable clusters: C1, the distal meridian-following group (BL37, GB35, GB30, GB34, ST36, BL57), primarily consisting of lower-limb points, suitable for patients with referred pain in the lower limbs; C2, the lumbar local group (EX-B2, GV3, BL25, BL23, Ashi, BL40), concentrated in the lumbosacral region emphasizing local point selection, with BL40 included due to its classical pairing; and C3, the syndrome differentiation group, comprises nine points (GV4, BL28, BL54, BL17, BL32, BL60, GV2, BL26, and KI3) along the Du Meridian and the Kidney Meridian, suggesting a combined local and constitutional regulatory strategy. Fifth, comparative analysis with LDH. In comparison with the data-mining findings of Zheng et al on LDH, both DLBP and LDH exhibit shared foundational elements in acupuncture practice most notably consistent high-frequency use of the Foot Taiyang Bladder Meridian and BL40 (Weizhong) underscoring a common neuroanatomical and functional substrate for low back pain management. However, their acupoint selection strategies diverge meaningfully: DLBP prioritises local lesion-targeted intervention including Ashi points and EX-B2 (Jiaji) and thermal modulation via warm-needle acupuncture or moxibustion, aligning with its TCM pathogenesis of cold-damp obstruction; in contrast, LDH treatment emphasises distal meridian-regulatory points particularly GB30 (Huantiao) and GB34 (Yanglingquan) combined with blood-activating and meridian-unblocking approaches to resolve qi stagnation and blood stasis secondary to nerve root compression. In summary, this study constitutes the first systematic, evidence-driven characterisation of acupoint selection patterns specific to DLBP. By delineating distinct clinical rules rooted in differential pathophysiology and validated through rigorous data mining, it provides a robust, condition-specific foundation for acupuncture practice that is methodologically and therapeutically independent of LDH.